SCHEMBL7947668

SCHEMBL7947668

Cc1ncsc1-c1cccc(F)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
THPO P40225 1/20 0.48
LMNA P02545 1/20 0.47
PMP22 Q01453 1/20 0.47
KDM4E B2RXH2 2/20 0.42
MEN1 O00255 1/20 0.42
MAPT P10636 1/20 0.42
KMT2A Q03164 1/20 0.42
ACHE P22303 1/20 0.39
VHL P40337 1/20 0.39
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
PIM1 P11309 1/20 0.38
TAAR1 Q96RJ0 1/20 0.38
ESR2 Q92731 1/20 0.38
MGAM O43451 1/20 0.38
GAA P10253 1/20 0.38
SI P14410 1/20 0.38
MGAM2 Q2M2H8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2094685 0.82 MEN1 (0.41) MEN1KMT2AACHEVHLADORA1
SCHEMBL27331301 0.79 HSD17B1 (0.50) CYP3A4VHL
SCHEMBL2097058 0.79 VHL (0.39) CYP1A2CYP3A4THPOLMNAPMP22
SCHEMBL16067424 0.79 KMT2A (0.42) CYP1A2LMNAMAPTKMT2AESR2
SCHEMBL14308609 0.79 CYP3A4 (0.48) CYP1A2CYP3A4THPOLMNAPMP22
SCHEMBL679793 0.77 KDM4E (0.53) LMNAKDM4EMEN1MAPTKMT2A
SCHEMBL8040677 0.77 DYRK1A (0.51) CYP1A2CYP3A4LMNAKDM4EMAPT
SCHEMBL2092341 0.76 ADORA2A (0.46) CYP1A2CYP3A4THPOLMNAPMP22
SCHEMBL25006724 0.74 BRD4 (0.50) KDM4EVHLPDGFRBPDGFRA
SCHEMBL1340272 0.74 KDM4E (0.69) CYP1A2CYP3A4THPOLMNAPMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7919507-B2 N-aroyl cyclic amines SMITHKLINE BEECHAM LIMITED (GB) 2011-04-05 US disclosed
US-7741329-B2 N-aroyl cyclic amines SMITHKLINE BEECHAM LIMITED (GB) 2010-06-22 US disclosed
WO-2010004507-A1 THIAZOLIDINE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2010-01-14 WO disclosed
US-20090093478-A1 N-AROYL CYCLIC AMINES SMITHKLINE BEECHAM P.I.C. 2009-04-09 US disclosed
US-20090029986-A1 N-AROYL CYCLIC AMINES SMITHKLINE BEECHAM P.L.C. 2009-01-29 US disclosed
US-20090012073-A1 N-AROYL CYCLIC AMINES SMITHKLINE BEECHAM P.L.C. 2009-01-08 US disclosed
US-7432270-B2 N-aroyl cyclic amines SMITHKLINE BEECHAM P.L.C. (GB) 2008-10-07 US disclosed
EP-1956020-A2 1-[2-(heterocyclyl-aminomethyl)-piperidin-1-YL]-1-(2-methyl-5-phenyl-heterocyclyl)-methanone derivatives and related compounds as orexin-1 antagonists for the treatment of obesity SMITHKLINE BEECHAM PLC (GB) 2008-08-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012073-A1 N-AROYL CYCLIC AMINES AANAT, MAOA, MAOB CYP1A2 31/4885CYP3A4 78/4885THPO 1469/4885
US-20090093478-A1 N-AROYL CYCLIC AMINES AANAT, MAOA, MAOB CYP1A2 31/4885CYP3A4 78/4885THPO 1469/4885
US-20090029986-A1 N-AROYL CYCLIC AMINES AANAT, MAOA, MAOB CYP1A2 31/4885CYP3A4 78/4885THPO 1469/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.